Verona Pharma PLC
NASDAQ:VRNA
Verona Pharma PLC
Revenue
Verona Pharma PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Verona Pharma PLC
NASDAQ:VRNA
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Revenue
£30.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
AstraZeneca PLC
LSE:AZN
|
Revenue
$47.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
6%
|
|
Indivior PLC
LSE:INDV
|
Revenue
$1.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Revenue
$2.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Revenue
£761.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
See Also
What is Verona Pharma PLC's Revenue?
Revenue
0
USD
Based on the financial report for Dec 31, 2023, Verona Pharma PLC's Revenue amounts to 0 USD.